Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06694155 · ClinicalTrials.gov registry record · NA
Whey Protein Ingestion and Glucose Control in Pre- and Post Diabetic Individuals
A NA study of Prediabetes / Type 2 Diabetes, sponsored by University of Arkansas.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06694155 is a NA study of Prediabetes / Type 2 Diabetes that is actively recruiting participants, run by University of Arkansas. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06694155, a NA study of Prediabetes / Type 2 Diabetes, is actively recruiting participants, sponsored by University of Arkansas.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
To examine the effects of twice daily whey protein consumption on blood glucose and insulin in pre-diabetic and diabetic individuals
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Whey Protein Isolate Crossover
Study Locations (1)
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-01-15 |
| Est. Completion | 2026-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06694155
The ClinicalTrials.gov registry entry for NCT06694155 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prediabetes / Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06694155 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.
Frequently Asked Questions
What is clinical trial NCT06694155 about?
NCT06694155 is a clinical study titled "Whey Protein Ingestion and Glucose Control in Pre- and Post Diabetic Individuals". To examine the effects of twice daily whey protein consumption on blood glucose and insulin in pre-diabetic and diabetic individuals
What is the current status of trial NCT06694155?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-01-15. Estimated completion is 2026-11-01.
What conditions does trial NCT06694155 study?
This clinical trial studies the following conditions: Prediabetes / Type 2 Diabetes.
What interventions are being tested in trial NCT06694155?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Whey Protein Isolate Crossover (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06694155?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06694155 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prediabetes / Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.